(+)-dexrazoxane increases expression ISO RGD:1550428 6480464 Dexrazoxane results in increased expression of CRAT mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRAT mRNA] CTD PMID:31150632 1,2-dichloroethane increases expression ISO RGD:1550428 6480464 ethylene dichloride results in increased expression of CRAT mRNA CTD PMID:28960355 1,4-benzoquinone decreases expression ISO RGD:1350289 6480464 quinone results in decreased expression of CRAT mRNA CTD PMID:32478940 17alpha-ethynylestradiol multiple interactions ISO RGD:1550428 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRAT mRNA CTD PMID:17942748 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CRAT mRNA CTD PMID:35192832 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550428 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRAT mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CRAT mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550428 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550428 6480464 Tetrachlorodibenzodioxin affects the expression of CRAT mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1350289 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA CTD PMID:21998131 2,4-D increases activity ISO RGD:1550428 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased activity of CRAT protein CTD PMID:1755024 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CRAT mRNA CTD PMID:21346803 2-(4-chloro-2-methylphenoxy)propanoic acid increases activity ISO RGD:1550428 6480464 mecoprop results in increased activity of CRAT protein CTD PMID:1755024 2-butoxyethanol increases expression ISO RGD:1550428 6480464 n-butoxyethanol results in increased expression of CRAT mRNA CTD PMID:19812364 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of CRAT mRNA CTD PMID:15953391 4,4'-sulfonyldiphenol increases expression ISO RGD:1350289 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CRAT protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO RGD:1550428 6480464 Fenretinide results in increased expression of CRAT mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CRAT mRNA CTD PMID:36843608 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CRAT mRNA CTD PMID:30047161 acetyl-CoA decreases activity EXP 6480464 Acetyl Coenzyme A deficiency results in decreased activity of CRAT protein CTD PMID:8075222 aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of CRAT mRNA CTD PMID:25450479 aristolochic acid A increases expression ISO RGD:1350289 6480464 aristolochic acid I results in increased expression of CRAT mRNA, aristolochic acid I results in increased expression of CRAT protein CTD PMID:33212167 atrazine increases expression ISO RGD:1350289 6480464 Atrazine results in increased expression of CRAT mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1550428 6480464 Benzo(a)pyrene results in decreased expression of CRAT mRNA CTD PMID:22228805 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1350289 6480464 Benzo(a)pyrene results in decreased expression of CRAT mRNA CTD PMID:32234424 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA CTD PMID:18164116 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of CRAT protein CTD PMID:3421940 more ... bezafibrate multiple interactions EXP 6480464 etomoxir inhibits the reaction [Bezafibrate results in increased activity of CRAT protein] CTD PMID:3421940 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1550428 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CRAT mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550428 6480464 Diethylhexyl Phthalate results in increased expression of CRAT mRNA CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CRAT mRNA CTD PMID:25181051 , PMID:35192832 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CRAT mRNA CTD PMID:32145629 Bisphenol B increases expression ISO RGD:1350289 6480464 bisphenol B results in increased expression of CRAT protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1350289 6480464 bisphenol F results in increased expression of CRAT protein CTD PMID:34186270 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CRAT mRNA CTD PMID:32479839 Butoxyacetic acid decreases activity EXP 6480464 n-butoxyacetic acid results in decreased activity of CRAT protein CTD PMID:4035690 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CRAT mRNA CTD PMID:19167457 cadmium atom increases oxidation ISO RGD:1550428 6480464 Cadmium results in increased oxidation of CRAT protein CTD PMID:24496640 carbon nanotube increases expression ISO RGD:1550428 6480464 Nanotubes, Carbon results in increased expression of CRAT mRNA CTD PMID:25620056 carmustine decreases expression ISO RGD:1350289 6480464 Carmustine results in decreased expression of CRAT mRNA CTD PMID:15980968 choline multiple interactions ISO RGD:1550428 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:1550428 6480464 Ciguatoxins affects the expression of CRAT mRNA CTD PMID:18353800 ciprofibrate increases expression ISO RGD:1550428 6480464 ciprofibrate results in increased expression of CRAT mRNA CTD PMID:12771043 Clinofibrate increases activity EXP 6480464 clinofibrate results in increased activity of CRAT protein CTD PMID:3625448 clofibrate multiple interactions ISO RGD:1550428 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1550428 6480464 Clofibrate results in increased expression of CRAT mRNA CTD PMID:23811191 more ... clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CRAT mRNA, Clofibrate results in increased expression of CRAT protein CTD PMID:12851107 more ... clofibrate multiple interactions EXP 6480464 Nicardipine results in decreased activity of [Clofibrate results in increased expression of CRAT protein] CTD PMID:1914008 clofibrate increases activity EXP 6480464 Clofibrate results in increased activity of CRAT protein CTD PMID:3625448 cobalt dichloride decreases expression ISO RGD:1350289 6480464 cobaltous chloride results in decreased expression of CRAT mRNA CTD PMID:19376846 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of CRAT mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of CRAT mRNA CTD PMID:26033743 copper(II) sulfate decreases expression ISO RGD:1350289 6480464 Copper Sulfate results in decreased expression of CRAT mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1350289 6480464 Cyclosporine results in decreased expression of CRAT mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:1550428 6480464 Cyclosporine results in decreased expression of CRAT mRNA CTD PMID:19770486 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CRAT mRNA CTD PMID:23640034 diazinon increases methylation ISO RGD:1350289 6480464 Diazinon results in increased methylation of CRAT gene CTD PMID:22964155 dichloroacetic acid increases expression ISO RGD:1550428 6480464 Dichloroacetic Acid results in increased expression of CRAT mRNA CTD PMID:28962523 doxorubicin decreases expression ISO RGD:1550428 6480464 Doxorubicin results in decreased expression of CRAT mRNA CTD PMID:26873546 elemental selenium increases expression ISO RGD:1350289 6480464 Selenium results in increased expression of CRAT mRNA CTD PMID:19244175 epoxiconazole increases expression ISO RGD:1550428 6480464 epoxiconazole results in increased expression of CRAT mRNA CTD PMID:35436446 Ethoxyacetic acid decreases activity EXP 6480464 ethoxyacetic acid results in decreased activity of CRAT protein CTD PMID:4035690 fenofibrate increases expression ISO RGD:1550428 6480464 Fenofibrate results in increased expression of CRAT mRNA CTD PMID:11798191 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CRAT mRNA CTD PMID:27665778 , PMID:32741897 fenofibrate increases activity EXP 6480464 Fenofibrate results in increased activity of CRAT protein CTD PMID:17264098 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased activity of CRAT protein, [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA CTD PMID:18253720 finasteride increases expression EXP 6480464 Finasteride results in increased expression of CRAT mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CRAT mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:1550428 6480464 Flutamide results in decreased expression of CRAT mRNA CTD PMID:19442681 folic acid multiple interactions ISO RGD:1550428 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene CTD PMID:20938992 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CRAT mRNA CTD PMID:27665778 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CRAT mRNA CTD PMID:24136188 glycidyl methacrylate decreases expression ISO RGD:1350289 6480464 glycidyl methacrylate results in decreased expression of CRAT protein CTD PMID:36641056 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA CTD PMID:22129741 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CRAT mRNA CTD PMID:36868495 isotretinoin decreases expression ISO RGD:1350289 6480464 Isotretinoin results in decreased expression of CRAT mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1350289 6480464 Ivermectin results in decreased expression of CRAT protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1550428 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRAT gene CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1550428 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA CTD PMID:18313992 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CRAT mRNA CTD PMID:24136188 mecoprop increases activity ISO RGD:1550428 6480464 mecoprop results in increased activity of CRAT protein CTD PMID:1755024 mercury dichloride decreases activity EXP 6480464 Mercuric Chloride results in decreased activity of CRAT protein CTD PMID:8075222 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CRAT mRNA CTD PMID:30047161 methoxyacetic acid decreases activity EXP 6480464 methoxyacetic acid results in decreased activity of CRAT protein CTD PMID:4035690 monosodium L-glutamate multiple interactions ISO RGD:1550428 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CRAT mRNA CTD PMID:19001666 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CRAT mRNA CTD PMID:21515302 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA CTD PMID:22129741 N-nitrosodiethylamine increases expression ISO RGD:1550428 6480464 Diethylnitrosamine results in increased expression of CRAT mRNA CTD PMID:12771043 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CRAT mRNA more ... CTD PMID:18164116 more ... nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CRAT mRNA CTD PMID:24136188 nicardipine multiple interactions EXP 6480464 Nicardipine results in decreased activity of [Clofibrate results in increased expression of CRAT protein] CTD PMID:1914008 nickel atom decreases expression ISO RGD:1350289 6480464 Nickel results in decreased expression of CRAT mRNA CTD PMID:24768652 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CRAT mRNA CTD PMID:24136188 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CRAT mRNA CTD PMID:23665939 ozone decreases expression ISO RGD:1550428 6480464 Ozone results in decreased expression of CRAT mRNA CTD PMID:12763052 ozone increases expression EXP 6480464 Ozone results in increased expression of CRAT mRNA CTD PMID:35737395 ozone multiple interactions EXP 6480464 [Coconut Oil co-treated with Ozone] results in decreased expression of CRAT mRNA more ... CTD PMID:33217375 ozone decreases expression EXP 6480464 Ozone results in decreased expression of CRAT mRNA CTD PMID:33217375 , PMID:33524448 paracetamol multiple interactions ISO RGD:1550428 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CRAT mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:1550428 6480464 Acetaminophen affects the expression of CRAT mRNA CTD PMID:17562736 perfluorohexanesulfonic acid increases expression ISO RGD:1550428 6480464 perfluorohexanesulfonic acid results in increased expression of CRAT mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:1550428 6480464 perfluoro-n-nonanoic acid results in increased expression of CRAT mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1550428 6480464 perfluorooctane sulfonic acid results in increased expression of CRAT mRNA CTD PMID:28558994 perfluorooctanoic acid multiple interactions ISO RGD:1550428 6480464 Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of CRAT mRNA] CTD PMID:23626681 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CRAT mRNA CTD PMID:28511854 perfluorooctanoic acid increases expression ISO RGD:1350289 6480464 perfluorooctanoic acid results in increased expression of CRAT mRNA, perfluorooctanoic acid results in increased expression of CRAT protein CTD PMID:23978341 more ... perfluorooctanoic acid increases expression ISO RGD:1550428 6480464 perfluorooctanoic acid results in increased expression of CRAT mRNA CTD PMID:17681415 more ... permethrin increases expression ISO RGD:1550428 6480464 Permethrin results in increased expression of CRAT mRNA CTD PMID:30629241 phenformin increases expression EXP 6480464 Phenformin results in increased expression of CRAT mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:1550428 6480464 Phenobarbital affects the expression of CRAT mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1550428 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CRAT mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of CRAT mRNA] CTD PMID:17950772 more ... pirinixic acid increases expression ISO RGD:1550428 6480464 pirinixic acid results in increased expression of CRAT mRNA CTD PMID:11798191 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CRAT mRNA CTD PMID:22484513 more ... potassium dichromate increases expression ISO RGD:1350289 6480464 Potassium Dichromate results in increased expression of CRAT protein CTD PMID:23718831 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of CRAT mRNA CTD PMID:27225895 pravastatin affects expression ISO RGD:1550428 6480464 Pravastatin affects the expression of CRAT mRNA CTD PMID:27225895 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CRAT mRNA CTD PMID:28374803 selenium atom increases expression ISO RGD:1350289 6480464 Selenium results in increased expression of CRAT mRNA CTD PMID:19244175 sodium fluoride increases expression ISO RGD:1550428 6480464 Sodium Fluoride results in increased expression of CRAT protein CTD PMID:28918527 sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of CRAT mRNA CTD PMID:25450479 tert-butyl hydroperoxide decreases expression ISO RGD:1350289 6480464 tert-Butylhydroperoxide results in decreased expression of CRAT mRNA CTD PMID:15336504 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CRAT mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO RGD:1550428 6480464 Tetrachloroethylene results in increased expression of CRAT mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRAT mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CRAT mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:1550428 6480464 Tetracycline results in decreased expression of CRAT mRNA CTD PMID:16917069 thapsigargin increases expression ISO RGD:1350289 6480464 Thapsigargin results in increased expression of CRAT mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CRAT mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1550428 6480464 titanium dioxide results in decreased expression of CRAT mRNA CTD PMID:23557971 trichloroethene affects expression ISO RGD:1550428 6480464 Trichloroethylene affects the expression of CRAT mRNA CTD PMID:21135412 trichloroethene increases expression ISO RGD:1550428 6480464 Trichloroethylene results in increased expression of CRAT mRNA CTD PMID:25549359 Tridiphane increases expression ISO RGD:1550428 6480464 tridiphane results in increased expression of CRAT protein CTD PMID:3590187 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CRAT mRNA CTD PMID:30589522 triptonide affects expression ISO RGD:1550428 6480464 triptonide affects the expression of CRAT mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CRAT mRNA CTD PMID:21515302 tunicamycin increases expression ISO RGD:1350289 6480464 Tunicamycin results in increased expression of CRAT mRNA CTD PMID:22378314 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CRAT mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1550428 6480464 Valproic Acid affects the expression of CRAT mRNA CTD PMID:17292431 valproic acid affects expression ISO RGD:1350289 6480464 Valproic Acid affects the expression of CRAT mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1350289 6480464 Valproic Acid results in increased methylation of CRAT gene CTD PMID:29154799 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CRAT mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO RGD:1550428 6480464 squalestatin 1 results in increased expression of CRAT mRNA CTD PMID:27225895 zidovudine multiple interactions ISO RGD:1550428 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of CRAT mRNA CTD PMID:18313992 zoledronic acid decreases expression ISO RGD:1550428 6480464 zoledronic acid results in decreased expression of CRAT mRNA CTD PMID:28871336
